XOMA Co. (NASDAQ:XOMAP) Short Interest Down 68.5% in January

XOMA Co. (NASDAQ:XOMAP) was the recipient of a large drop in short interest during the month of January. As of January 30th, there was short interest totaling 627 shares, a drop of 68.5% from the January 15th total of 1,989 shares. Based on an average daily volume of 737 shares, the short-interest ratio is currently 0.9 days. Based on an average daily volume of 737 shares, the short-interest ratio is currently 0.9 days.

XOMA Trading Down 0.7%

XOMAP stock opened at $25.86 on Wednesday. The business’s fifty day moving average price is $26.55 and its 200 day moving average price is $26.37. XOMA has a 12-month low of $24.96 and a 12-month high of $30.00.

About XOMA

XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.

Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.